Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06971757

HAKA: Routine Follow-Up at 1 Year After Hip- or Knee Arthroplasty: Wasting Resources or Appropriate Healthcare?

Cost-effectiveness of Routine Follow-up at One Year After Total Hip and Knee Arthroplasty Compared to Check-up on Demand: a Multicenter Hybrid Stepped-wedge Cluster De-implementation Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
JointResearch · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

After undergoing total hip or total knee arthroplasty, current guidelines recommend routine follow-up with an X-ray within 3 months and again at 1 year. Follow-up at 5 years (for hip arthroplasties) or every 5 years (for knee arthroplasties) is also considered worthwhile according to the guideline. However, these follow-up appointments require considerable time from patients, caregivers, and healthcare professionals, and it is unclear whether they are truly beneficial. It is possible that a single follow-up within 3 months is sufficient. This could potentially prevent over 100,000 unnecessary hospital visits per year, resulting in significant cost savings. If patients or healthcare providers have concerns, they can always request an additional follow-up. The HAKA trial consists of three different work packages (WPs). This trial (WP1) investigates the 1-year follow-up, WP2 examines the 10-year follow-up, and WP3 is a qualitative study exploring the experiences and perceptions of patients and healthcare professionals. The aim of the HAKA trial is to safely reduce routine follow-up appointments after total hip or knee arthroplasty and to revise current clinical guidelines accordingly.

Conditions

Interventions

TypeNameDescription
OTHERRoutine Follow-Up (RFU)Standard follow-up care with scheduled X-ray and clinical visit at 3 months and 1 year after surgery.
OTHERCheck-Up on Demand (COD)Follow-up care with scheduled X-ray and clinical visit at 3 months and only at 1 year if requested.

Timeline

Start date
2025-07-01
Primary completion
2028-08-31
Completion
2029-12-31
First posted
2025-05-14
Last updated
2025-11-18

Locations

9 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06971757. Inclusion in this directory is not an endorsement.